Relmada Therapeutics Inc (NAS:RLMD)
$ 3.53 -0.27 (-7.11%) Market Cap: 106.52 Mil Enterprise Value: 18.34 Mil PE Ratio: 0 PB Ratio: 1.24 GF Score: 31/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1